Skip to main content

Advertisement

Springer Nature Link
Log in

Current concepts of pain management for cancer patients

  • Review
  • Published:
Oncology Reviews

Abstract

Pain management is one of the most important issues confronted when treating patients with malignant diseases. Since its release/publication in 1986, the World Health Organization’s three-step analgesic ladder has helped to greatly improve pain management in cancer patients. However, many questions about this three-step analgesic ladder have been raised and its application in the clinical setting remains a controversial subject. This review article explores the frontline treatment of cancer pain with morphine and the different routes of fentanyl administration used in cancer pain management. The combination of multiple opiates/opioids has been shown to result in more effective cancer pain management; however, the exact benefits of such opiate/opioid combinations have yet to be established. This article also discusses recent advances in the topical application of morphine and in the combination of ketamine and morphine. It explores the updated treatment principles of neuropathic pain in advanced-stage cancer patients, which incorporate the use of anti-depressants, anti-convulsants, and opioids. Finally, this article reviews the available data and clarifies the general principles for using opioids in cancer patients with renal insufficiency. We hope that this information will be helpful in improving pain management in cancer patients and in facilitating further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zeppetella G, Ribeiro MD (2003) Pharmacotherapy of cancerrelated episodic pain. Expert Opin Pharmacother 4:493–502

    Article  PubMed  CAS  Google Scholar 

  2. World Health Organization (1987) Alivio del dolor en el cancer. World Health Organization, Geneva Switzerland

    Google Scholar 

  3. McDonnell FJ, Sloan JW, Hamann SR (2001) Advances in cancer pain management. Curr Pain Headache Rep 5:265–271

    Article  PubMed  CAS  Google Scholar 

  4. Seymour J, Clark D, Winslow M (2005) Pain and palliative care: the emergence of new specialities. J Pain Symptom Manage 29:2–13

    Article  PubMed  Google Scholar 

  5. Meldrum M (2005) The ladder and the clock: cancer pain and public policy at the end of the twentieth century. J Pain Symptom Manage 29:41–54

    Article  PubMed  Google Scholar 

  6. Walsh D (2005) Advances in opioid therapy and formulations. Support Care Cancer 13:138–144

    Article  PubMed  Google Scholar 

  7. Grond S, Radbruch L, Meuser T et al (1999) Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79:15–20

    Article  PubMed  CAS  Google Scholar 

  8. Maltoni M, Scarpi E, Modonesi C et al (2005) Avalidation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 13:888–894

    Article  PubMed  Google Scholar 

  9. Marinangeli F, Ciccozzi A, Leonardis M et al (2004) Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 27:409–416

    Article  PubMed  CAS  Google Scholar 

  10. Dean M (2004) Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28:497–504

    Article  PubMed  CAS  Google Scholar 

  11. Mystakidou K, Katsouda E, Parpa E et al (2005) Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. Am J Hosp Palliat Care 22:228–232

    Article  PubMed  Google Scholar 

  12. Burton AW, Driver LC, Mendoza TR, Syed G (2004) Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain 20:195–197

    Article  PubMed  Google Scholar 

  13. Gourlay GK (2001) Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2:165–172

    Article  PubMed  CAS  Google Scholar 

  14. Menahem S, Shvartzman P (2004) High-dose fentanyl patch for cancer pain. J Am Board Fam Pract 17:388–390

    Article  PubMed  Google Scholar 

  15. Meadows M (2006) In: Proper use of fentanyl pain patches. Food and Drug Administration Consumer Magazine March–April. Available via DIALOG. http://www.fda.gov/fdac/features/2006/206_fentanyl.html. Accessed 20 May 2008

  16. Evans R (2003) The effectiveness of transdermal fentanyl in palliative care. Nurs Times 99:24–25

    PubMed  Google Scholar 

  17. Kornick CA, Santiago-Palma J, Moryl N et al (2003) Benefitrisk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 26:951–973

    Article  PubMed  CAS  Google Scholar 

  18. Soares LG, Martins M, Uchoa R (2003) Intravenous fentanyl for cancer pain: a “fast titration” protocol for the emergency room. J Pain Symptom Manage 26:876–881

    Article  PubMed  CAS  Google Scholar 

  19. Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12:762–766

    Article  PubMed  Google Scholar 

  20. Davis MP, LeGrand SB, Lagman R (2005) Look before leaping: combined opioids may not be the rave. Support Care Cancer 13:769–774

    Article  PubMed  Google Scholar 

  21. Zeppetella G, Paul J, Ribeiro MD (2003) Analgesic efficacy of morphine applied to painful ulcers. J Pain Symptom Manage 25:555–558

    Article  PubMed  CAS  Google Scholar 

  22. Pol O, Alameda F, Puig MM (2001) Inflammation enhances muopioid receptor transcription and expression in mice intestine. Mol Pharmacol 60:894–899

    PubMed  CAS  Google Scholar 

  23. Cerchietti L (2007) Morphine mouthwashes for painful mucositis. Support Care Cancer 15:115–116; author reply 117

    Article  PubMed  Google Scholar 

  24. Zeppetella G, Ribeiro MD (2005) Morphine in intrasite gel applied topically to painful ulcers. J Pain Symptom Manage 29:118–119

    Article  PubMed  Google Scholar 

  25. Long TD, Cathers TA, Twillman R et al (2001) Morphine-Infused silver sulfadiazine (MISS) cream for burn analgesia: a pilot study. J Burn Care Rehabil 22:118–123

    Article  PubMed  CAS  Google Scholar 

  26. Cerchietti L (2007) Morphine mouthwashes for painful mucositis. Support Care Cancer 15:115–116; author reply 117

    Article  PubMed  Google Scholar 

  27. Cerchietti LC, Navigante AH, Korte MW et al (2003) Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105:265–273

    Article  PubMed  CAS  Google Scholar 

  28. Cerchietti LC, Navigante AH, Bonomi MR et al (2002) Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95:2230–2236

    Article  PubMed  CAS  Google Scholar 

  29. Gairard-Dory AC, Schaller C, Mennecier B et al (2005) Chemoradiotherapy-induced esophagitis pain relieved by topical morphine: three cases. J Pain Symptom Manage 30:107–109

    Article  PubMed  Google Scholar 

  30. Kolesnikov YA, Pasternak GW (1999) Peripheral blockade of topical morphine tolerance by ketamine. Eur J Pharmacol 374:R1–R2

    Article  PubMed  CAS  Google Scholar 

  31. Kolesnikov YA, Chereshnev I, Pasternak GW (2000) Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 295:546–551

    PubMed  CAS  Google Scholar 

  32. Gallagher RE, Arndt DR, Hunt KL (2005) Analgesic effects of topical methadone: a report of four cases. Clin J Pain 21:190–192

    Article  PubMed  Google Scholar 

  33. Krajnik M, Zylicz Z (1997) Topical morphine for cutaneous cancer pain. Palliat Med 11:325

    Article  PubMed  CAS  Google Scholar 

  34. Watterson G, Howard R, Goldman A (2004) Peripheral opioids in inflammatory pain. Arch Dis Child 89:679–681

    Article  PubMed  CAS  Google Scholar 

  35. Bell RF, Eccleston C, Kalso E (2003) Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J Pain Symptom Manage 26:867–875

    Article  PubMed  CAS  Google Scholar 

  36. Bell R, Eccleston C, Kalso E (2003) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev:CD003351

  37. Mercadante S, Arcuri E, Tirelli W, Casuccio A (2000) Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 20:246–252

    Article  PubMed  CAS  Google Scholar 

  38. Lossignol DA, Obios-Portis M, Body J (2005) Successful use of ketamine for intractable cancer pain. Support Care Cancer 13:188–193

    Article  PubMed  Google Scholar 

  39. Kannan TR, Saxena A, Bhatnagar S, Barry A (2002) Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage 23:60–65

    Article  PubMed  CAS  Google Scholar 

  40. Fitzgibbon EJ, Hall P, Schroder C, Seely J et al (2002) Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine. J Pain Symptom Manage 23:165–170

    Article  PubMed  Google Scholar 

  41. Kotlinska-Lemieszek A, Luczak J (2004) Subanesthetic ketamine: an essential adjuvant for intractable cancer pain. J Pain Symptom Manage 28:100–102

    Article  PubMed  Google Scholar 

  42. Fitzgibbon EJ, Viola R (2005) Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit. J Palliat Med 8:49–57

    Article  PubMed  Google Scholar 

  43. Bryson J, Tamber A, Seccareccia D, Zimmermann C (2006) Methadone for treatment of cancer pain. Curr Oncol Rep 8:282–288

    Article  PubMed  CAS  Google Scholar 

  44. Mannino R, Coyne P, Swainey C et al (2006) Methadone for cancer-related neuropathic pain: a review of the literature. J Opioid Manag 2:269–276

    PubMed  Google Scholar 

  45. Bryson J, Tamber A, Seccareccia D, Zimmermann C (2006) Methadone for treatment of cancer pain. Curr Oncol Rep 8:282–288

    Article  PubMed  CAS  Google Scholar 

  46. Benítez-Rosario MA, Feria M, Salinas-Martínez-Castollo LP, Martín-Ortega JJ (2004) Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 101:2866–2873

    Article  PubMed  CAS  Google Scholar 

  47. Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571–591

    Article  PubMed  CAS  Google Scholar 

  48. Clifford DB (1985) Treatment of pain with antidepressants. Am Fam Physician 31:181–185

    PubMed  CAS  Google Scholar 

  49. Katherine E, Galluzzi DO (2007) Managing neuropathic pain. J Am Osteopath Assoc 107:ES39–ES48

    Google Scholar 

  50. Kalso E, Tasmuth T, Neuvonen PJ (1996) Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 64:293–302

    Article  PubMed  CAS  Google Scholar 

  51. Tasmuth T, Härtel B, Kalso E (2002) Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6:17–24

    Article  PubMed  CAS  Google Scholar 

  52. Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev:CD005451

  53. Backonja MM (2000) Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 16:S67–S72

    PubMed  CAS  Google Scholar 

  54. Luo ZD, Calcutt NA, Higuera ES (2002) Injury type-specific calcium channel a2d subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effect of gabapentin. J Pharmcol Exp Ther 303:1199–1205

    Article  CAS  Google Scholar 

  55. Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22:2909–2917

    Article  PubMed  CAS  Google Scholar 

  56. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev:CD005452

  57. Siddall PJ, Cousins MJ, Otte A et al (2006) Pregabalin in central neuropathic pain associated with spinal cord injury: a placebocontrolled trial. Neurology 67:1792–1800

    Article  PubMed  CAS  Google Scholar 

  58. Enggaard TP, Klitgaard NA, Sindrup SH (2006) Specific effect of levetiracetam in experimental human pain models. Eur J Pain 10:193–198

    Article  PubMed  CAS  Google Scholar 

  59. Moulin DE, Clark AJ, Gilron I et al (2007) Pharmacological management of chronic neuropathic pain — consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12:13–21

    PubMed  CAS  Google Scholar 

  60. Davis MP (2007) What is new in neuropathic pain? Support Care Cancer 15:363–372

    Article  PubMed  Google Scholar 

  61. Durnin C, Hind ID, Ghani SP et al (2001) Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment. Proc West Pharmacol Soc 44:83–84

    PubMed  CAS  Google Scholar 

  62. Izzedine H, Launay-Vacher V, Abbara C et al (2002) Pharmacokinetics of tramadol in a hemodialysis patient. Nephron 92:755–756

    Article  PubMed  Google Scholar 

  63. Launay-Vacher V, Karie S, Fau JB et al (2005) Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted. J Pain 6:137–148

    Article  PubMed  Google Scholar 

  64. Nagaoka E, Minami K, Shiga Y et al (2002) Tramadol has no effect on cortical renal blood flow — despite increased serum catecholamine levels — in anesthetized rats: implications for analgesia in renal insufficiency. Anesth Analg 94:619–625

    Article  PubMed  CAS  Google Scholar 

  65. McClain DA, Hug CC (1980) Intravenous fentanyl kinetics. Clin Pharmacol Ther 28:106–114

    PubMed  CAS  Google Scholar 

  66. D’Honneur G, Gilton A, Sandouk P et al (1994) Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure. Anesthesiology 81:87–93

    CAS  Google Scholar 

  67. Lugo RA, Satterfield KL, Kern SE (2005) Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19:13–24

    Article  PubMed  Google Scholar 

  68. Filitz J, Griessinger N, Sittl R et al (2006) Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J Pain 10:743–748

    Article  PubMed  CAS  Google Scholar 

  69. Boger RH (2006) Renal impairment: a challenge for opioid treatment? The role of buprenorphine. Palliat Med 20[Suppl 1]:s17–s23

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M.D. Anderson Cancer Center, Holcombe Houston, Texas, USA

    Sai-Ching Jim Yeung

  2. Chi-Mei Medical Center, Liouying Campus, Tainan, Taiwan, China

    Yin-Hsun Feng

  3. Institute of Clinical Medicine, Medical School, National Cheng Kung University, Tainan, Taiwan, China

    Yin-Hsun Feng

  4. Hospice Unit, Tzu Chi University, School of Medicine, Hualien, Taiwan, China

    Ying-Wai Wang

Authors
  1. Yin-Hsun Feng
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Ying-Wai Wang
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Sai-Ching Jim Yeung
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Sai-Ching Jim Yeung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, YH., Wang, YW. & Jim Yeung, SC. Current concepts of pain management for cancer patients. Oncol Rev 2, 154–163 (2008). https://doi.org/10.1007/s12156-008-0071-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12156-008-0071-3

Keywords